Phase 1 Study of Accelerated Hypofractionated Radiation Therapy With Concurrent Chemotherapy for Stage III Non-Small Cell Lung Cancer: CALGB 31102 (Alliance)
- 19 January 2018
- journal article
- research article
- Published by Elsevier BV in International Journal of Radiation Oncology*Biology*Physics
- Vol. 101 (1), 177-185
- https://doi.org/10.1016/j.ijrobp.2018.01.046
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Establishing the feasibility of the dosimetric compliance criteria of RTOG 1308: phase III randomized trial comparing overall survival after photon versus proton radiochemotherapy for inoperable stage II-IIIB NSCLCRadiation Oncology, 2016
- Phase 1 Dose Escalation Study of Accelerated Radiation Therapy With Concurrent Chemotherapy for Locally Advanced Lung CancerInternational Journal of Radiation Oncology*Biology*Physics, 2015
- SOCCAR: A randomised phase II trial comparing sequential versus concurrent chemotherapy and radical hypofractionated radiotherapy in patients with inoperable stage III Non-Small Cell Lung Cancer and good performance statusEuropean Journal of Cancer, 2014
- Dose-Limiting Toxicity After Hypofractionated Dose-Escalated Radiotherapy in Non–Small-Cell Lung CancerJournal of Clinical Oncology, 2013
- Radiotherapy Protocol Deviations and Clinical Outcomes: A Meta-analysis of Cooperative Group Clinical TrialsJNCI Journal of the National Cancer Institute, 2013
- Image Guided Hypofractionated 3-Dimensional Radiation Therapy in Patients With Inoperable Advanced Stage Non-Small Cell Lung CancerInternational Journal of Radiation Oncology*Biology*Physics, 2013
- Phase I Study of Accelerated Conformal Radiotherapy for Stage I Non–Small-Cell Lung Cancer in Patients With Pulmonary Dysfunction: CALGB 39904Journal of Clinical Oncology, 2010
- A Phase II Study of Synchronous Three-Dimensional Conformal Boost to the Gross Tumor Volume for Patients With Unresectable Stage III Non–Small-Cell Lung Cancer: Results of Korean Radiation Oncology Group 0301 StudyInternational Journal of Radiation Oncology*Biology*Physics, 2009
- Dose-escalating conformal thoracic radiation therapy with induction and concurrent carboplatin/paclitaxel in unresectable stage IIIA/B nonsmall cell lung carcinomaCancer, 2001
- Phase I/II study of treatment of locally advanced (T3/T4) non-oat cell lung cancer with concomitant boost radiotherapy by the radiation therapy oncology group (RTOG 83-12): long-term resultsInternational Journal of Radiation Oncology*Biology*Physics, 1995